Ranson M and Sliwkowski MX |
Perspectives on anti-HER monoclonal antibodies. |
2002 |
Oncology |
pmid:12422051
|
Tolcher AW et al. |
Cantuzumab mertansine, a maytansinoid immunoconjugate directed to the CanAg antigen: a phase I, pharmacokinetic, and biologic correlative study. |
2003 |
J. Clin. Oncol. |
pmid:12525512
|
Pullen CB et al. |
Occurrence and non-detectability of maytansinoids in individual plants of the genera Maytenus and Putterlickia. |
2003 |
Phytochemistry |
pmid:12620351
|
Hamel E |
Natural products which interact with tubulin in the vinca domain: maytansine, rhizoxin, phomopsin A, dolastatins 10 and 15 and halichondrin B. |
1992 |
Pharmacol. Ther. |
pmid:1287674
|
Cruz-Monserrate Z et al. |
Dolastatin 15 binds in the vinca domain of tubulin as demonstrated by Hummel-Dreyer chromatography. |
2003 |
Eur. J. Biochem. |
pmid:12950266
|
Sieber SM et al. |
Pharmacology of antitumor agents from higher plants. |
1976 |
Cancer Treat Rep |
pmid:136296
|
Yue XF et al. |
Cytotoxic activity of trewiasine in 4 human cancer cell lines and 5 murine tumors. |
1992 |
Zhongguo Yao Li Xue Bao |
pmid:1442109
|
Osieka R et al. |
Chemotherapy of human colon cancer xenografts in athymic nude mice. |
1977 |
Cancer |
pmid:144557
|
Spiteller P et al. |
The post-polyketide synthase modification steps in the biosynthesis of the antitumor agent ansamitocin by Actinosynnema pretiosum. |
2003 |
J. Am. Chem. Soc. |
pmid:14624546
|
Xie H et al. |
Pharmacokinetics and biodistribution of the antitumor immunoconjugate, cantuzumab mertansine (huC242-DM1), and its two components in mice. |
2004 |
J. Pharmacol. Exp. Ther. |
pmid:14634038
|